JPRN-UMIN000015853
已完成
未知
Study of the Influenza vaccine immune response using PMMA dialyzer. - Influenza vaccine effectiveness in using PMMA dialyzer
Oita naika clinic0 个研究点目标入组 50 人2014年12月4日
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- End-stage renal disease requiring hemodialysis
- 发起方
- Oita naika clinic
- 入组人数
- 50
- 状态
- 已完成
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- 未提供
排除标准
- •A patient who is judged as the inadequate subject of this study by the doctor.
结局指标
主要结局
未指定
相似试验
已完成
不适用
Study of the Influenza vaccine immune response using PMMA dialyzer.JPRN-UMIN000019455Oita University Hospital Blood purification center120
进行中（未招募）
1 期
Evaluation of how body's defense system against infection responds to the flu vaccine in cancer patients being treated with idelalisibTo assess the immune response to an influenza vaccine in subjects with B-cell malignancies treated with idelalisibMedDRA version: 20.0 Level: PT Classification code 10065856 Term: Non-Hodgkin's lymphoma unspecified histology indolent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2017-003055-30-ESGilead Sciences, Inc.22
进行中（未招募）
1 期
Evaluation of how body's defense system against infection responds to the flu vaccine in cancer patients being treated with idelalisibTo assess the immune response to an influenza vaccine in subjects with B-cell malignancies treated with idelalisibMedDRA version: 20.0 Level: PT Classification code 10065856 Term: Non-Hodgkin's lymphoma unspecified histology indolent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2017-003055-30-CZGilead Sciences, Inc.22
进行中（未招募）
1 期
Evaluation of how body's defense system against infection responds to the flu vaccine in cancer patients being treated with idelalisibEUCTR2017-003055-30-PLGilead Sciences, Inc.22
进行中（未招募）
1 期
Evaluation of how body's defense system against infection responds to the flu vaccine in cancer patients being treated with idelalisibEUCTR2017-003055-30-FRGilead Sciences, Inc.22